S

Sharp Therapeutics
SHRX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CA$135.04M
EV
CA$132.52M
Shares Outstanding
31.25M
Beta
-1.41
Industry
-

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E E
-
P/Revenue E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Sharp Therapeutics Corp.

gainify

S

Sharp Therapeutics Corp.

SHRX

Sharp Therapeutics Corp., a preclinical-stage drug discovery company, developes therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies, enables discovery of compounds that correct the mutational defect; ...

Sector

Industry

CEO

Sneddon, Scott

Employees

IPO Date

Headquarters

2403 Sidney Street, Suite 264, Pittsburgh, Pennsylvania, 15203, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.